论文部分内容阅读
目的分析支气管哮喘心理治疗的临床效果。方法 201例支气管哮喘患者作为研究对象,随机分为观察组(101例)与对照组(100例)。对照组患者仅给予常规药物治疗,观察组患者在对照组基础上再配合心理治疗方式,观察比较两组患者治疗后的效果差异。结果治疗后,观察组焦虑、抑郁自评量表评分均明显低于对照组,差异有统计学意义(P<0.05)。观察组支气管哮喘临床症状得到控制99例(98%),对照组控制92例(92%),观察组症状控制率明显高于对照组,差异有统计学意义(P<0.05)。观察组和对照组一秒用力呼气容积(FEV1)改善比例分别为(0.69±0.32)、(0.37±0.24)%,最大呼气流量(PEF)指标改善情况分别为(0.52±0.22)、(0.40±0.18)L/s;观察组肺功能指标改善情况优于对照组,差异有统计学意义(P<0.05)。结论支气管哮喘患者在常规药物治疗基础上再行心理治疗能改善患者负面心理情绪,辅助提升临床疗效,应用效果良好,值得推广应用。
Objective To analyze the clinical effect of psychological treatment of bronchial asthma. Methods Totally 201 patients with bronchial asthma were randomly divided into observation group (101 cases) and control group (100 cases). Patients in the control group were given only conventional drug treatment. The patients in the observation group were treated with psychotherapy on the basis of the control group. The differences in the effects after treatment between the two groups were observed and compared. Results After treatment, the scores of anxiety and depression self-rating scale in the observation group were significantly lower than those in the control group, the difference was statistically significant (P <0.05). The clinical symptoms of bronchial asthma were controlled 99 cases (98%) in the observation group and 92 cases (92%) in the control group. The symptom control rate in the observation group was significantly higher than that in the control group (P <0.05). The improvement rates of FEV1 in observation group and control group were (0.69 ± 0.32) and (0.37 ± 0.24)% respectively, and the improvement of maximum expiratory flow (PEF) were (0.52 ± 0.22) and 0.40 ± 0.18) L / s. The improvement of pulmonary function indexes in the observation group was better than that in the control group (P <0.05). Conclusion Patients with bronchial asthma re-psychotherapy based on conventional drug therapy can improve the negative emotions of patients and help to improve the clinical curative effect. The application effect is good and it is worth popularizing and applying.